Audit committee

Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Ocugen, Inc. (OCGN)

Retrieved on: 
Thursday, April 11, 2024
LLP, News, EY, Complaint, Audit committee, Bank statement, SAN, Person, Audit

SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Ocugen, Inc. (NASDAQ: OCGN) securities between May 8, 2020 and April 1, 2024.

Key Points: 
  • SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Ocugen, Inc. (NASDAQ: OCGN) securities between May 8, 2020 and April 1, 2024.
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • If you choose to take no action, you can remain an absent class member.

Zuora Appoints John D. Harkey, Jr. to Board of Directors

Retrieved on: 
Wednesday, May 1, 2024
Software, Technology, Professional Services, Business, Agreement, University, Investment, LP, Audit committee, Principal, Therapy, Novartis, Moses Austin, Novartis Gene Therapies, Management

Zuora, Inc. (NYSE: ZUO), a leading monetization suite for modern business, today announced the appointment of John D. Harkey, Jr. to the Zuora Board of Directors, effective April 30, 2024.

Key Points: 
  • Zuora, Inc. (NYSE: ZUO), a leading monetization suite for modern business, today announced the appointment of John D. Harkey, Jr. to the Zuora Board of Directors, effective April 30, 2024.
  • With the addition of Mr. Harkey, the Zuora Board of Directors will consist of ten Board members, nine of whom are independent.
  • Over the course of his career, Mr. Harkey has previously served on the board of directors of nine public companies.
  • Mr. Harkey currently serves on the Board of Directors and Audit Committee of Lionsgate Entertainment Corp., is the Chairman of the Board of Directors of Dialectic Therapeutics, Inc., and Chairman of the Board of Veterinary Service, Inc. Mr. Harkey received his B.B.A.

Autodesk, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the ADSK Securities Class Action

Retrieved on: 
Monday, April 29, 2024
Class Action Lawsuit, Professional Services, Legal, LLP, News, 3D, Engineering, Complaint, Audit committee, ADSK, Form 10-K, Person

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Autodesk, Inc. (NASDAQ: ADSK) securities between June 1, 2023 and April 16, 2024.

Key Points: 
  • Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Autodesk, Inc. (NASDAQ: ADSK) securities between June 1, 2023 and April 16, 2024.
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • If you choose to take no action, you can remain an absent class member.

Lineage Announces Changes to Board of Directors

Retrieved on: 
Monday, April 29, 2024
Biotechnology, Health, Stem Cells, Mallinckrodt, Sale, University, General counsel, Economics, Compensated emancipation, Audit committee, PJT Partners, Bachelor of Arts, Therapy, Senior advisor, Asterias, Management

Mr. Kingsley served as Chairman of the Company’s Board of Directors since July 2009, and was a significant contributor in the evolution of the Company into a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs.

Key Points: 
  • Mr. Kingsley served as Chairman of the Company’s Board of Directors since July 2009, and was a significant contributor in the evolution of the Company into a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs.
  • Effective as of April 27, 2024, Michael H. Mulroy, J.D., has been appointed by the Board of Directors to serve as the Chairman of the Board of Directors.
  • “Al was exceptionally committed to Lineage and its shareholders, and brought great innovation, leadership, and dedication to others to his work.
  • He previously served as Chief Executive Officer and a member of the board of directors of Asterias Biotherapeutics, Inc.

ADSK INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Autodesk, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on: 
Monday, April 29, 2024
Class Action Lawsuit, Professional Services, Legal, News, Annual report, Security (finance), 3D, Attention, Engineering, Commission, Audit committee, ADSK, Committee, Tobacco

), the Autodesk class action lawsuit charges Autodesk and certain of Autodesk’s top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • ), the Autodesk class action lawsuit charges Autodesk and certain of Autodesk’s top executives with violations of the Securities Exchange Act of 1934.
  • Lead plaintiff motions for the Autodesk class action lawsuit must be filed with the court no later than June 24, 2024.
  • The lead plaintiff can select a law firm of its choice to litigate the Autodesk class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Autodesk class action lawsuit.

The Chemours Company Investors Should Contact Robbins LLP Before the Expiration of the Lead Plaintiff Deadline in the Lawsuit Against CC

Retrieved on: 
Thursday, April 11, 2024
LLP, Person, Refrigeration, News, Air conditioning, Transport, Ethics, Controller, Senior, Complaint, Audit committee, Electronics, Plastic, Annual report, CC, SAN, Management

For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

Key Points: 
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • What Now: You may be eligible to participate in the class action against The Chemours Company.
  • Shareholders who want to serve as lead plaintiff for the class must file their papers with the court by May 20, 2024.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

Kessler Topaz Meltzer & Check, LLP Notifies Investors That the Firm Has Filed a Class Action Lawsuit Against The Chemours Company (CC)

Retrieved on: 
Thursday, April 11, 2024
Lead, CFO, LLP, Annual report, COPY, Collection, Ethics, Controller, Senior, District court, Audit committee, Court, Form 10-K, Adjustment, CC, Cryptocurrency

RADNOR, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company ( NYSE: CC ) (“Chemours” or the “Company”) on behalf of investors who purchased or acquired Chemours common stock between February 10, 2023 and February 28, 2024, inclusive (the “Class Period”).

Key Points: 
  • RADNOR, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company ( NYSE: CC ) (“Chemours” or the “Company”) on behalf of investors who purchased or acquired Chemours common stock between February 10, 2023 and February 28, 2024, inclusive (the “Class Period”).
  • This action, captioned Taylor Jr. v. The Chemours Company, et al., Case No.
  • Important Deadline Reminder: Investors who purchased or otherwise acquired Chemours common stock during the Class Period may, no later than May 20, 2024, move the Court to serve as lead plaintiff for the class.
  • Kessler Topaz Meltzer & Check, LLP encourages Chemours investors who have suffered significant losses to contact the firm directly to acquire more information.

EQIX INVESTOR NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Equinix, Inc. Investors to Inquire About Securities Class Action Investigation – EQIX

Retrieved on: 
Wednesday, April 10, 2024
Titan, EQIX, News, Advertising, Real estate investment trust, Equinix, Real estate investing, Hindenburg Research, The Insider, Audit committee, Hindenburg

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23498 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE

Retrieved on: 
Wednesday, April 10, 2024
Titan, Bluebird, News, Advertising, EY, Audit committee, Bank statement, Audit

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=23843 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Equinix (EQIX) Falls After Disclosing Internal Investigation and DOJ Subpoena - Hagens Berman

Retrieved on: 
Wednesday, April 10, 2024
EQIX, Real estate investment trust, AI, Machine learning, Hindenburg Research, The Insider, Audit committee, Hindenburg, Bank statement, REIT, Hagens Berman, SAN, Person

SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Equinix, Inc. (NASDAQ: EQIX) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Equinix, Inc. (NASDAQ: EQIX) investors who suffered substantial losses to submit your losses now .
  • 25, 2024, Equinix disclosed announced that the Audit Committee of the company’s Board of Directors has commenced an independent investigation to review the matters referenced in a recent short seller report.
  • Equinix further disclosed that after the release of the report, the company received a subpoena from the U.S. Attorney’s Office for the Northern District of California.
  • “We’re investigating whether Equinix may have inflated key financial metrics to appear more profitable,” said Reed Kathrein, the Hagens Berman partner leading the investigation.